EP. 1: Understanding Tropomyosin Receptor Kinase Inhibitors
EP. 2: Preliminary Safety/Efficacy Data for Larotrectinib
EP. 3: How Will Larotrectinib Be Used?
EP. 4: Entrectinib's Value as a TRK Inhibitor
EP. 5: TRK Inhibition's Potential Role in Clinical Practice
EP. 6: Next-Generation Sequencing for TRK Inhibition
EP. 7: Challenges With NGS for TRK Inhibition
EP. 8: NGS Across Tumor Types for TRK Inhibition
EP. 9: Optimal Use of NGS for TRK Inhibition
EP. 10: TRK Inhibition: Ongoing Challenges
EP. 11: Moving Forward With TRK Inhibition
Oncology Experts Preview Top Abstracts From 2025 ASCO GU
Dr Somaiah on Ongoing Research With Novel Agents in Sarcomas
Dr Hamid on the Potential for Cancer Vaccines in Melanoma
Dr Orloff on Treatment Strategies for Rapidly Progressing Uveal Melanoma